VentureBeat
RSS
Subscribe By Email
Main
DigitalMedia
LifeScience
CleanTech
Mobile/Comm
«
Co-founder of Bebo leaves ...
Main
Antibody-drug maker Raven Biotech ...
»
Chemokine-drug maker ChemoCentryx files for $58M IPO
David P. Hamilton
|
November 13th, 2007
See our story about this Mountain View, Calif., biotech at
VentureBeat Life Sciences
.
View the entire comment thread.
Trackback URL
VentureBeat Wire
Guest Columnists
Top Stories
Market rallies as U.S. automaker, bank and ...
How badly could a recession hurt cleantech? ...
Google prepping special iPhone ads?
Stock market swings wildly -- plunges, then ...
Orkut on the iPhone — a Brazilian ...
Recent Comments
Powered by Disqus
Recent Guest Columnists
Marty Abbott and Michael Fisher
The cloud isn’t for everyone
William Quigley
Remaining objective when fear is in the air
Todd Kimmel
What to expect from cleantech in the downturn
Job Board
Product Manager
at
True Knowledge
(Cambridge, Cambridgeshire, UK)
Interactive Production Designer
at
EyeWonder, Inc
(233 Peachtree Street Atlanta, GA 30303)
Alliance Marketing Consultant BP
at
Sun Microsystems
(MENLO PARK, CA)
More Jobs »
|
Post a Job »
Links
About VentureBeat
Contact Matt Marshall (guarded by anti-spam solution)
Story Tips (anti-spam protection)
Advertise on VentureBeat (spam protection)
Contact VentureBeat Team (spam protection)
Freelance for VentureBeat (spam protection)
Blogroll
Twitter
VentureBeat Sponsors
Venturebeat Writers
Matt Marshall
, Editor-in-Chief
Dean Takahashi
, Lead Writer, DigitalMedia
Eric Eldon
, Editor, DigitalMedia
MG Siegler
, Writer, DigitalMedia
Anthony Ha
, Writer, VentureBeat
Chris Morrison
, Writer, CleanTech
For advertising, contact
Jacob Mullins (spam protection)
.
Log in
Forbes.com Technology Headlines
Come On Now, Hit 'Submit'
'Spore's' Sprawl
Ten Things You Should Know About 'Dead Space'
Font Size
SMALL
|
MEDIUM
|
BIG